<DOC>
	<DOCNO>NCT01836146</DOCNO>
	<brief_summary>The purpose First-in-Human Clinical investigation evaluate safety performance St. Jude Medical EnligHTN™ Generation 2 Renal Denervation System treatment patient drug-resistant uncontrolled hypertension .</brief_summary>
	<brief_title>International First-in-Human Study EnligHTN Generation 2 System Patients With Drug-resistant Uncontrolled Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Subject ≥ 18 ≤ 80 year age time consent Subject must able willing provide write informed consent Subject must able willing comply require followup schedule Subject office Systolic Blood Pressure ≥ 160 mmHg confirmatory visit Subject daytime mean Systolic Ambulatory Blood Pressure &gt; 135 mmHg two week screen period Subject office Systolic Blood Pressure remain ≥160 mmHg despite stable use ≥3 antihypertensive medication concurrently maximally tolerated dos , one diuretic subject previously diuretic document diuretic intolerant , minimum 14 day prior procedure expectation maintain minimum 180 day post procedure . Subject significant renovascular abnormality renal artery stenosis &gt; 30 % either renal artery Subject undergone prior renal angioplasty , renal denervation , indwell renal stent , and/or abdominal aortic stent graft Subject hemodynamically significant valvular heart disease determine Study Investigator Subject life expectancy le 12 month , determine Study Investigator Subject participate another clinical study potential impact hypertension management ( pharmaceutical/device/homeopathic ) Subject pregnant , nursing , childbearing potential use adequate contraceptive method Subject active systemic infection Subject renal artery diameter ( ) &lt; 4 mm diameter &lt; 20 mm length Subject estimate Glomerular Filtrate Rate ( eGFR ) &lt; 45 mL/min per 1.73 m2 use Modified Diet Renal Disease ( MDRD ) formula Subject Diabetes Mellitus Type I Subject multiple main renal artery either kidney Subject identify secondary cause hypertension ( example , include , limited , Polycystic kidney disease , Cushing 's syndrome , Aldosteronism ) Subject evidence significant abdominal aortic aneurysm ( define maximum diameter &gt; 4 cm ) Subject myocardial infarction , unstable angina pectoris cerebrovascular accident le 180 day prior enrollment Subject expect cardiovascular intervention within next 180 day Subject condition would interfere accurate interpretation study objective include limited large arm diameter unable accommodate blood pressure cuff arrhythmia interfere automatic pulse sensing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>